The aim of the present study was to determine whether the immunohistochemical expression of AdipoR-1, AdipoR-2 or ObR correlates with the clinicopathological manifestations and clinical outcomes of endometrial carcinoma patients. Here, LEPR is linked to endometrial carcinoma.